The allylic 7-ketone at the steroidal skeleton is crucial for the antileukemic potency of chlorambucil's active metabolite steroidal esters

被引:24
作者
Arsenou, ES
Fousteris, MA
Koutsourea, AI
Papageorgiou, A
Karayianni, V
Mioglou, E
Iakovidou, Z
Mourelatos, D
Nikolaropoulos, SS [1 ]
机构
[1] Univ Patras, Sch Hlth Sci, Lab Pharmaceut Chem, Dept Pharm, Rion Patras 26500, Greece
[2] Theagen Anticanc Inst, Lab Expt Chemotherapy, Thessaloniki, Greece
[3] Aristotle Univ, Sch Med, Lab Biol & Genet, Thessaloniki, Greece
关键词
antileukemic activity; chlorambucil; steroidal allylic 7-ketone; steroidal esters; structure-activity relationships;
D O I
10.1097/00001813-200411000-00008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have investigated the role of the allylic 7-ketone in oxidized Delta(5)-steroids on antileukernic activity. We synthesized and studied a series of oxidized and non-oxidized steroidal esters of p-N,N-bis(2-chloroethyl) aminophenylacetic acid (PHE), chlorambucil's active metabolite. In a comparative study of these 7-keto derivatives, on a molecular basis, regarding their ability to induce sister chromatid exchanges (SCEs) and to inhibit cell proliferation in normal human lymphocytes in vitro, the results with these 7-keto derivatives, on a molecular basis, correlated well with their antileukernic potency against leukemia P388- and L1210-bearing mice, which proved to be significantly increased compared to that of the nonoxidized derivatives. Our results indicate that the role of the steroidal skeleton it is not only for the transportation of the alkylating agent into the cell, but also contributes directly to the mechanism of antileukernic action, by an as-yet unknown way. The main conclusion from this study is that the existence of the allylic 7-keto group in the skeleton of the Delta(5)-steroidal esters impressively enhances their antileukernic activity, while the toxicity remains at clinically acceptable levels, suggesting that this structural modification should be further investigated. (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码:983 / 990
页数:8
相关论文
共 60 条
[51]  
PETTERSSONFERNH.T, 1999, J CHEM SOC P2, V2, P2183
[52]   DNA cross-linking agents as antitumor drugs [J].
Rajski, SR ;
Williams, RM .
CHEMICAL REVIEWS, 1998, 98 (08) :2723-2795
[53]   17-AZA-D-HOMOSTEROIDS AND 17A-AZA-D-HOMOSTEROIDS [J].
REGAN, BM ;
HAYES, FN .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1956, 78 (03) :639-643
[54]  
SATO Y, 1984, CHEM PHARM BULL, V32, P3305
[55]   Macromolecular derivatives of N,N-di-(2-chloroethyl)-4-phenylene diamine mustard.: 2.: In vitro cytotoxicity and in vivo anticancer efficacy [J].
Soyez, H ;
Seymour, LW ;
Schacht, E .
JOURNAL OF CONTROLLED RELEASE, 1999, 57 (02) :187-196
[56]  
STARKA L, 1962, BIOCHIM BIOPHYS ACTA, V56, P76, DOI 10.1016/0006-3002(62)90528-0
[57]  
TOLIFON P, 1985, CANCER RES, V45, P2025
[58]   CHOLESTEROL-BIOSYNTHESIS AND 3-HYDROXY-3-METHYL-GLUTARYL COENZYME A REDUCTASE IN CULTURED GLIAL AND NEURONAL CELLS - REGULATION BY LIPOPROTEIN AND BY CERTAIN FREE STEROLS [J].
VOLPE, JJ ;
HENNESSY, SW .
BIOCHIMICA ET BIOPHYSICA ACTA, 1977, 486 (03) :408-420
[59]   EFFECTS OF SOME STEROIDAL ALKYLATING AGENTS ON EXPERIMENTAL ANIMAL MAMMARY TUMOR AND LEUKEMIA SYSTEMS [J].
WALL, ME ;
ABERNETHY, GS ;
CARROLL, FI ;
TAYLOR, DJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1969, 12 (05) :810-+
[60]   ADJUVANT THERAPY IN STAGE-I AND STAGE-II EPITHELIAL OVARIAN-CANCER - RESULTS OF 2 PROSPECTIVE RANDOMIZED TRIALS [J].
YOUNG, RC ;
WALTON, LA ;
ELLENBERG, SS ;
HOMESLEY, HD ;
WILBANKS, GD ;
DECKER, DG ;
MILLER, A ;
PARK, R ;
MAJOR, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (15) :1021-1027